Time to next episode of cellulitis · People with recurrent erysipelas or cellulitis
Antibiotic prophylaxis probably leads to lower time to next episode of cellulitis compared with no treatment/placebo (moderate certainty).
1 finding from 1 review
Hospital admissions · People with recurrent erysipelas or cellulitis
Antibiotic prophylaxis showed no clear difference in hospitalisation compared with no treatment/placebo (low certainty).
1 finding from 1 review
Adverse reactions to treatment Proportion of participants with adverse reactions to treatment · People with recurrent erysipelas or cellulitis
Antibiotic prophylaxis showed no clear difference in any adverse reactions compared with no treatment/placebo (low certainty).
1 finding from 1 review
Quality of life · People with recurrent erysipelas or cellulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global outcome (good or excellent improvement in symptoms or signs, or both) · people with eczema
Topical steroid plus topical antibiotic showed no clear difference in global outcome (good or excellent improvement in symptoms or signs,… compared with topical steroid (low certainty).
1 finding from 1 review
Change from baseline in quality of life IDQoL ranges from 0 to 30 with higher values indicating more impaired quality of life · people with eczema
1 finding from 1 review
Withdrawals due to adverse events · people with eczema
It is very uncertain whether topical steroid plus topical antibiotic changes adverse events requiring withdrawal from treatment compared with topical steroid (very low certainty).
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · people with eczema
It is very uncertain whether topical steroid plus topical antibiotic changes minor adverse events not requiring withdrawal from treatment compared with topical steroid (very low certainty).
1 finding from 1 review
Global change in composite ratings scale EASI ranges from 0 to 72, objective SCORAD ranges from 0 to 83 and SCORAD ranges from 0 to 108, with higher values indicating greater severity. · people with eczema
1 finding from 1 review
No of participants in whom S. aureus was isolated · people with eczema
Topical steroid plus topical antibiotic probably leads to lower no of participants in whom S. aureus was isolated compared with topical steroid (moderate certainty).
1 finding from 1 review
Microbiology Emergence of resistant organisms · people with atopic dermatitis
1 finding from 1 review
Remission · participants with acne
Herbal medicine showed no clear difference in secondary outcome: number of participants with remission (ITT‐best… compared with antibiotics (low certainty).
2 findings from 1 review